T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Blue Bird Corp
BLBD
$2.05B
| $18.5M | ﹤0.01% |
1,694,899
+58,128
| +4% | +$1.06M |
|
1102
Pinnacle West Capital
PNW
$12.2B
| $18.3M | ﹤0.01% |
242,087
+15,354
| +7% | +$1.39M |
|
|
CHUY
1103
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $18.3M | ﹤0.01% |
1,818,778
+119,426
| +7% | +$2.5M |
|
1104
SEACOR Marine Holdings
SMHI
$262M
| $18.2M | ﹤0.01% |
4,153,740
+73,028
| +2% | +$643K |
|
|
GTT
1105
DELISTED
GTT Communications, Inc.
GTT
| $18.2M | ﹤0.01% |
2,287,140
-546,405
| -19% | -$6.6M |
|
1106
W.P. Carey
WPC
$16.3B
| $18.2M | ﹤0.01% |
319,535
+26,158
| +9% | +$1.98M |
|
1107
Team
TISI
$101M
| $18.1M | ﹤0.01% |
277,990
-427
| -0.2% | -$52.9K |
|
1108
Hercules Capital
HTGC
$3.17B
| $18.1M | ﹤0.01% |
2,362,589
+9,096
| +0.4% | +$119K |
|
1109
Regions Financial
RF
$27B
| $17.9M | ﹤0.01% |
1,994,186
+146,705
| +8% | +$2.05M |
|
|
ZGNX
1110
DELISTED
Zogenix, Inc.
ZGNX
| $17.8M | ﹤0.01% |
719,324
-619,965
| -46% | -$22.6M |
|
1111
American Public Education
APEI
$828M
| $17.7M | ﹤0.01% |
741,690
+48,952
| +7% | +$1.19M |
|
1112
Kimbell Royalty Partners
KRP
$1.52B
| $17.7M | ﹤0.01% |
3,044,338
+1,270,522
| +72% | +$15.3M |
|
1113
AES
AES
$10.5B
| $17.6M | ﹤0.01% |
1,296,812
+104,398
| +9% | +$1.87M |
|
1114
Option Care Health
OPCH
$3.61B
| $17.5M | ﹤0.01% |
1,844,932
+1,275,491
| +224% | +$18.7M |
|
1115
Blackstone
BX
$112B
| $17.4M | ﹤0.01% |
381,226
+40,123
| +12% | +$2.22M |
|
1116
Gray Television
GTN
$520M
| $17.3M | ﹤0.01% |
1,607,150
-9,298
| -0.6% | -$168K |
|
|
CATM
1117
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $17.2M | ﹤0.01% |
822,317
-5,980
| -0.7% | -$226K |
|
1118
Lamb Weston
LW
$7.39B
| $17.1M | ﹤0.01% |
300,010
+29,045
| +11% | +$2.39M |
|
1119
Huntington Bancshares
HBAN
$35.9B
| $17.1M | ﹤0.01% |
2,077,735
+160,720
| +8% | +$1.98M |
|
1120
Brunswick
BC
$5.29B
| $16.9M | ﹤0.01% |
478,697
-263,544
| -36% | -$14M |
|
1121
Peabody Energy
BTU
$2.94B
| $16.8M | ﹤0.01% |
5,790,493
+569,095
| +11% | +$3.64M |
|
1122
Ardelyx
ARDX
$1.01B
| $16.7M | ﹤0.01% |
2,945,474
+260,751
| +10% | +$1.77M |
|
|
CNST
1123
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $16.6M | ﹤0.01% |
527,867
+124,292
| +31% | +$4.32M |
|
|
CCRN
1124
DELISTED
Cross Country Healthcare
CCRN
| $16.5M | ﹤0.01% |
2,449,434
-13,670
| -0.6% | -$129K |
|
|
GTHX
1125
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $16.4M | ﹤0.01% |
1,491,444
-308,740
| -17% | -$5.77M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.